DaVita Inc. logo

DaVita Inc. (DVA)

Market Closed
22 Jul, 20:00
NYSE NYSE
$
232. 08
-5.2
-2.1915%
$
15.21B Market Cap
16.41 P/E Ratio
- Div Yield
979,361 Volume
7.83 Eps
$ 237.28
Previous Close
Add Transaction
Day Range
230.35 237.11
Year Range
101 239.64
Want to track DVA and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
DaVita HealthCare (DVA) Upgraded to Strong Buy: Here's What You Should Know

DaVita HealthCare (DVA) Upgraded to Strong Buy: Here's What You Should Know

DaVita HealthCare (DVA) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

Zacks | 1 year ago
DaVita HealthCare (DVA) Up 13% Since Last Earnings Report: Can It Continue?

DaVita HealthCare (DVA) Up 13% Since Last Earnings Report: Can It Continue?

DaVita HealthCare (DVA) reported earnings 30 days ago. What's next for the stock?

Zacks | 1 year ago
DaVita Rallies 44% Year to Date: What's Driving the Stock?

DaVita Rallies 44% Year to Date: What's Driving the Stock?

DVA's shares gain on the back of strong fundamentals. However, dependence on commercial payers can be a cause of concern.

Zacks | 1 year ago
DaVita HealthCare (DVA) is a Great Momentum Stock: Should You Buy?

DaVita HealthCare (DVA) is a Great Momentum Stock: Should You Buy?

Does DaVita HealthCare (DVA) have what it takes to be a top stock pick for momentum investors? Let's find out.

Zacks | 1 year ago
3 Defensive Stocks Outperforming in a Choppy Market (PM, DVA, STWD)

3 Defensive Stocks Outperforming in a Choppy Market (PM, DVA, STWD)

Broad markets, although continuing to trend higher, are showing signs of increasing volatility and uncertainty. While there has been a strong rally in stocks since the sharp correction earlier in the month, there is something peculiar happening under the surface.

Zacks | 1 year ago
2 Must-Buy Medical Stocks With Strong Momentum

2 Must-Buy Medical Stocks With Strong Momentum

Two medical stocks with strong momentum and a favorable Zacks Rank are: DVA, ILMN.

Zacks | 1 year ago
Why DaVita HealthCare (DVA) is a Top Value Stock for the Long-Term

Why DaVita HealthCare (DVA) is a Top Value Stock for the Long-Term

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Zacks | 1 year ago
Is DaVita (DVA) Stock Undervalued Right Now?

Is DaVita (DVA) Stock Undervalued Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Zacks | 1 year ago
4 Stocks Trading Near 52-Week High With More Upside Potential

4 Stocks Trading Near 52-Week High With More Upside Potential

Investors target stocks that have lately been on a bull run. Stocks like PPC, THC, DVA and UHS are seeing price strength and have a high chance of carrying the momentum forward.

Zacks | 1 year ago
DaVita Inc. (DVA) Hits Fresh High: Is There Still Room to Run?

DaVita Inc. (DVA) Hits Fresh High: Is There Still Room to Run?

DaVita HealthCare (DVA) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Zacks | 1 year ago
DaVita HealthCare (DVA) Is Up 0.56% in One Week: What You Should Know

DaVita HealthCare (DVA) Is Up 0.56% in One Week: What You Should Know

Does DaVita HealthCare (DVA) have what it takes to be a top stock pick for momentum investors? Let's find out.

Zacks | 1 year ago
Is DaVita (DVA) a Great Value Stock Right Now?

Is DaVita (DVA) a Great Value Stock Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Zacks | 1 year ago
Loading...
Load More